Neomycin
Active ingredient · 9 therapeutic classes
Sold as ODAN-SPOR · VIADERM KC CRM · VIADERM KC ONT · DIOPTROL SUSPENSION · TRUE TEST 36
- Drug class
- Antibiotics
- Availability
- Prescription and OTC
- Routes
- Oral, Topical
- Markets covered
- 3
- Products on record
- 17
Overview
Neomycin is an active pharmaceutical ingredient in the Antibiotics group (A07AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 13 | April 17, 2026 |
| US United States | FDA | 2 | February 27, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
13 products
Uses
MAXITROL eye drops, suspension is indicated for the short-term treatment of steroid responsive conditions of the eye when prophylactic antibiotic treatment is also required, after excluding the presence of fungal and viral disease.
How to take
USUnited States· FDA
2 products
Uses
INDICATIONS AND USAGE
To reduce the development of drug-resistant bacteria and maintain the effectiveness of neomycin sulfate tablets and other antibacterial drugs, neomycin sulfate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
, preoperative preparation of the bowel. It is given concomitantly with erythromycin enteric-coated base (see DOSAGE AND ADMINISTRATION ). Hepatic Coma (Portal-Systemic Encephalopathy) Neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract.
CACanada· Health Canada
2 products
Uses
® Ointment are indicated for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida. ® Cream is indicated for Pruritus ani and pruritus vulvae.
Conditions most commonly infected include acute atopic dermatitis, exfoliative eythrodermas, neurodermatitis, nummular eczema, acute contact dermatitis, chronic eczema (except of lower leg), chronic familiar benign pemphigus and intertriginous lesions.
® Ointment contain antibiotic ingredients, gramicidin and neomycin. ® Ointment should only be used for the authorized indication and clinical use. C. C. ® Ointment are contraindicated as follow: In Patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container.
For a complete listing, see the Dosage Forms, Composition and Packaging section of the product monograph. 4 In Tuberculous and most viral lesions of the skin (including herpes simplex, vaccinia and varicella) and fungal skin lesions except candidiasis.
Drug interactions
Known interactions involving Neomycin. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL001011000 · revised February 20, 2026
- [2]FDA DailyMed · 0aa6947b-4739-4b… · revised February 27, 2026 [PDF]
- [3]Health Canada (DPD) · 00717002 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.